High-quality HIV antigens for cutting-edge solutions. On February 18, 2025, Gilead Sciences (CA, US) announced a significant milestone: the US FDA accepted their New Drug Applications (NDAs) for ...
Early HIV detection can mean the difference between a long, healthy life and severe complications. Learn why timing matters ...
Department of Defense initiative's first-use case would be for HIV vaccine delivery via a platform developed by a ...
Moderna's vaccines deliver HIV-specific antigens discovered by researchers at IAVI and Scripps Research that have already been tested in a proof-of-concept study carried out last year using an ...
Predictive values may be defined as the likelihood that a result is correct. Predictive values depend on prevalence of the target analyte. NPVs of HIV tests and testing strategies are always high ...
A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a ...
Hosted on MSN20d
Gilead’s capsid revolution meets our capsid solutions: Sino Biological – Engineering the tools to outsmart HIVAt Sino Biological, we are proud to support this era of progress with our industry-leading recombinant HIV antigen[ products. As the fight against HIV evolves, our high-quality antigens empower ...
In a medical first, a research team in China has successfully stitched a CRISPR gene-edited pig liver into a brain-dead ...
Large-scale data on the hepatitis D virus (HDV)/hepatitis B virus (HBV) co-infection rate is needed to estimate the current ...
What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results